A Retrospective Study of Anti-Vascular Endothelial Growth Factor (VEGF) Injections for Retinal Vein Occlusion or Diabetic Macular Edema

• Status: Completed
• Trial end date: 2014-09-04
• Target enrollment: 0
• Participant gender: All

Summary

This retrospective data review study will evaluate anti-VEGF injections for retinal vein occlusion (RVO) or diabetic macular edema (DME).

• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Allergan
• Treatments: Bevacizumab; Endothelial Growth Factors

Criteria

Inclusion Criteria:

• Macular edema in the study eye due to RVO or DME

• Received an anti-VEGF injection in the study eye on or after June 2010 for RVO and on or after August 2012 for DME

Exclusion Criteria:

• None